ERJ November Podcast: ERS statement on the diagnosis and treatment of pulmonary disease caused by a1-antitrypsin deficiency


Source: Eur Respir J, 50 (5) 17E5005; 10.1183/13993003.E5005-2017
Journal Issue: November

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
ERJ November Podcast: ERS statement on the diagnosis and treatment of pulmonary disease caused by a1-antitrypsin deficiency. Eur Respir J, 50 (5) 17E5005; 10.1183/13993003.E5005-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension
Source: Eur Respir J 2015; 46: E58
Year: 2015

European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency
Source: Eur Respir J, 50 (5) 1700610; 10.1183/13993003.00610-2017
Year: 2017



European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency
Source: Guideline 2017
Year: 2017


ERJ January Podcast: clinical guidelines for chronic pulmonary aspergillosis
Source: Eur Respir J 2016; 47: E61
Year: 2016

January Podcast: ERS guidelines on chronic cough
Source: Eur Respir J, 55 (1) 20E5501; 10.1183/13993003.E5501-2020
Year: 2020



ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2016; 48: E68
Year: 2016

ERJ September Podcast: The hidden burden of severe asthma
Source: Eur Respir J, 50 (3) 17E5003; 10.1183/13993003.E5003-2017
Year: 2017



ERJ March Podcast: Novel therapies in idiopathic pulmonary fibrosis
Source: Eur Respir J, 53 (3) 19E5303; 10.1183/13993003.E5303-2019
Year: 2019



The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress
Source: Eur Respir J 2015; 46: 879-882
Year: 2015


Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


Diagnosis and management of a1-antitrypsin deficiency in Europe: an expert survey
Source: ERJ Open Res, 5 (1) 00171-2018; 10.1183/23120541.00171-2018
Year: 2019



ERJ June Podcast: Chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J, 49 (6) 17E4906; 10.1183/13993003.E4906-2017
Year: 2017



WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
Source: Eur Respir Rev, 31 (163) 210165; 10.1183/16000617.0165-2021
Year: 2022



ERJ September Podcast: research priorities in bronchiectasis
Source: Eur Respir J 2016; 48: E69
Year: 2016

Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011
Source: Eur Respir J 2011; 37: 743-746
Year: 2011


ERJ December Podcast: Assessing the worldwide epidemiology of sarcoidosis
Source: Eur Respir J 2016; 48: E72
Year: 2016

ERJ February Podcast: precision medicine in chronic airway diseases
Source: Eur Respir J 2016; 47: E62
Year: 2016

Selected clinical highlights from the 2012 ERS congress in Vienna
Source: Eur Respir J 2013; 41: 1219-1227
Year: 2013



2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Source: Guideline 2015
Year: 2021